GlassScriptPhysician profile
William Randal Jones
NPI 1881672954
$1,372.38
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $137 · 2021: $253 · 2022: $307 · 2023: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $621.88 | 2019-2023 | |
| Pfizer INC. | $164.23 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.37 | 2019-2020 | |
| Exeltis, USA INC. | $78.34 | 2022-2023 | Slynd |
| Lupin INC. | $55.54 | 2019-2020 | |
| Astellas Pharma US INC | $46.30 | 2023 | Veozah |
| Organon LLC | $45.29 | 2022-2023 | |
| Novo Nordisk INC | $31.30 | 2022 | |
| Merck Sharp & Dohme LLC | $25.80 | 2019-2020 | |
| Shield Therapeutics INC | $24.29 | 2022 | |
| Axonics, INC. | $20.01 | 2022 | |
| Sage Therapeutics, LLC | $19.05 | 2021 | |
| Millicent US INC | $18.86 | 2020 | |
| Agile Therapeutics, INC. | $17.68 | 2023 | Twirla |
| Sumitomo Pharma America, INC. | $16.92 | 2023 | Myfembree |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $16.74 | 2023 | |
| Coopersurgical, INC. | $16.74 | 2022 | |
| Therapeuticsmd, INC. | $16.53 | 2020 | |
| Mission Pharmacal Company | $14.63 | 2021 | |
| Avion Pharmaceuticals | $14.28 | 2019 | |
| Lilly USA, LLC | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.